Patient Recruitment and CDISC: What We’re Talking About This Week

 Clinical trials again top our list with articles about patient recruitment and the growth of Big Data! 1. Patient empowerment key to trial recruitment, report finds  This article leads to a very interesting white paper discussing the inefficiencies of recruiting and retaining patients. 2. CDISC, TransCelerate release new standards for diabetes, cardiovascular disease  New standards for the diabetes […]

Drug Development Costs & Trial Diversity: What We’re Talking About This Week

 This week, drug development costs & clinical trial diversity are our Hot Topics! 1. Developing a Drug Costs $2.6 Billion, but not Everyone Believes This  Drug development is very costly, estimates vary but totals are well over $2 Billion. 2. Success or failure, feds want trial results posted online  No matter the outcome, federal regulators want clinical […]

CNS Drugs, eClinical Software & More: What We’re Talking About This Week

This week, we continue reading about clinical trial diversity with an article from I’m In, and we recommend articles about the slow development of CNS drugs, and how to choose eClinical software. 1.  Study: CNS drugs have lower regulatory success rate, take longer to develop A recent study shows that drugs developed for central nervous systems disorders […]

Blood Cancer Drug, Text Messaging & More: What We’re Talking About This Week

Our hot topics this week include a new blood cancer drug from Novartis, text messaging to increase clinical trial participation, and how the WHO director has condemned “Profit-Driven” Pharmas for not producing an Ebola cure. 1.  Novartis gears up for FDA scrutiny with a new blood cancer drug  The FDA advisers face a difficult task of having […]